英文論文
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
Yuki Kondo, Shinya Ohashi, Chikatoshi Katada, Yukie Nakai, Yoshihiro Yamamoto, Masashi Tamaoki, Osamu Kikuchi, Atsushi Yamada, Kenshiro Hirohashi, Yosuke Mitani, Shigeki Kataoka, Tomoki Saito, Trang H Nguyen Vu, Tomohiro Kondo, Yu Uneno, Tomohiko Sunami, Akira Yokoyama, Junichi Matsubara, Tomonari Matsuda, Seiji Naganuma, Kohei Oryu, Samuel Flashner, Masataka Shimonosono, Hiroshi Nakagawa, Manabu Muto.
Aldh2 and the tumor suppressor Trp53 play important roles in alcohol-induced squamous field cancerization.
J Gastroenterol. 2025 May;60(5):546-560.
Ikuo Aoyama, Kohei Takizawa, Kozo Kataoka, Gakuto Ogawa, Yusuke Sano, Yoshinobu Yamamoto, Tsutomu Tanaka, Takeshi Setoyama, Tomohiro Kadota, Yutaka Saito, Yasuaki Nagami, Takuto Hikichi, Shinji Nagata, Yuji Urabe, Hiroyuki Ono, Hisashi Doyama, Ko Nagino, Toshihiko Tomita, Masashi Tamaoki, Kazuya Ohno, Masaaki Kobayashi, Seiichiro Abe, Tomonori Yano, Manabu Muto.
Endoscopic balloon dilation with steroid injection versus radial incision and cutting with steroid for refractory esophageal anastomotic stricture: a randomized study.
Endoscopy. 2025 Sep;57(9):980-989.
Takashi Masuda, Taro Funakoshi, Takahiro Horimatsu, Sho Masui, Daiki Hira, Marin Inoue, Kodai Yajima, Shunsaku Nakagawa, Yasuaki Ikemi, Junzo Hamanishi, Atsushi Takai, Shinya Yamamoto, Takeshi Matsubara, Masaki Mandai, Hiroshi Seno, Motoko Yanagita, Manabu Muto, Tomohiro Terada, Atsushi Yonezawa.
Population pharmacokinetic analysis of bevacizumab in Japanese cancer patients with proteinuria: a prospective cohort study.
Cancer Chemother Pharmacol. 2025 Mar 21;95(1):46.
Matsubara Junichi, Mukai Kumi, Kondo Tomohiro, Yoshioka Masahiro, Kage Hidenori, Oda Katsutoshi, Ikeda Sadakatsu, Ebi Hiromichi, Muro Kei, Kajiura Shinya, Hayashi Ryuji, Ashida Reiko, Kitano Masayuki, Muto Manabu.
First-line genomic profiling in previously untreated advanced solid tumors: 1-year follow-up of the FIRST-Dx study.
Cancer Science.2025 Jul;116(7):1908-1919.
Kana Eguchi, Takeaki Kubota, Tomoyoshi Koyanagi, Manabu Muto.
Real-World Data on Alcohol Consumption Behavior Among Smartphone Health Care App Users in Japan: Retrospective Study
Online J Public Health Inform. 2025 Mar 25:17:e57084.
Chigusa Morizane, Makoto Ueno, Tatsuya Ioka, Masahiro Tajika, Masafumi Ikeda, Kensei Yamaguchi, Hiroki Hara, Hiroshi Yabusaki, Atsushi Miyamoto, Satoru Iwasa, Manabu Muto , Tsutomu Takashima, Keiko Minashi, Yoshito Komatsu, Tomohiro Nishina, Takako Eguchi Nakajima, Atsuchi Takeno, Toshikazu Moriwaki, Masayuki Furukawa, Takatoshi Sahara, Hiroki Ikezawa, Maiko Nomoto, Shuya Takashima, Taisuke Uehara, Setsuo Funasaka, Masakazu Yashiro, Junji Furuse.
Tasurgratinib in patients with cholangiocarcinoma or gastric cancer: Expansion part of the first-in-human phase I study.
Cancer Sci. 2025 Jan;116(1):192-203.
Riku Takahashi, Aya Tanaka, Tomoki Saito, Shinya Ohashi, Manabu Muto, Masumi Yamaguchi.
Organ-On-A-Chip Platforms Created Through Buckled Microchannels of Porous Hydrogel Films.
Adv Mater Technol. April 4, 2025
Motoo Nomura, Toshifumi Yamaguchi, Keisho Chin, Shinji Hato, Ken Kato, Eishi Baba, Hisahiro Matsubara, Hidenori Mukaida, Takako Yoshii, Masahiro Tsuda, Yasuhiro Tsubosa, Yuko Kitagawa, Isao Oze, Hideki Ishikawa, Manabu Muto.
Phase II Trial of Adjuvant S-1 Following Neoadjuvant Chemotherapy and Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: The PIECE Trial.
Ann Surg Oncol. 2025 Jan;32(1):302-311.
Naoya Toriu, Shinya Yamamoto, Takeshi Matsubara, Yuki Kataoka, Kaoru Sakai, Taro Funakoshi, Takahiro Horimatsu, Tatsuo Tsukamoto, Naoka Murakami, Kenar D Jhaveri, Shingo Fukuma, Tomohiro Terada, Manabu Muto, Shunichi Fukuhara, Motoko Yanagita; Onconephrology Consortium in Japan.
Cancer diagnosis and prognosis after initiation of hemodialysis: multicenter Japan CANcer and DialYsis (J-CANDY) study.
Clin Kidney J. 2024 Dec 20;18(2):sfae430.
Jun Okui, Kengo Nagashima, Satoru Matsuda, Yasunori Sato, Akihiko Okamura, Hirofumi Kawakubo, Manabu Muto, Yoshihiro Kakeji, Koji Kono, Hiroya Takeuchi, Masayuki Watanabe, Yuichiro Doki, Takeo Bamba, Takashi Fukuda, Hitoshi Fujiwara, Shinsuke Sato, Kazuhiro Noma, Hiroshi Miyata, Takeo Fujita, Yuko Kitagawa.
Recurrence-free survival as a surrogate endpoint for overall survival after neoadjuvant chemotherapy and surgery for oesophageal squamous cell carcinoma.
Br J Surg. 2024 Jan 31;111(2):znae038.






